Dr. Daniel J. Correa, MD

Media Releases

Leading Neurologist and Research Fellow Advocates for Increased Patient and Caregiver Involvement in Antiepileptogenic Treatment Trials

A devoted neurologist, Dr. Correa is the research fellow for the Public Engagement Core of The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx). In this pivotal role, he collaborates with a diverse consortium of researchers, clinicians, patient organizations, patients, and caretakers to promote and enhance public involvement in future treatment trials aimed at improving therapies for epilepsy and traumatic brain injury (TBI).

In addition to his research role, he serves as the Deputy Chief of Neurology at Montefiore Medical Center, and is an Assistant Professor of Neurology at the Albert Einstein College of Medicine. At Montefiore, he provides comprehensive care in inpatient general neurology, neurohospitalist, and epilepsy services. He also contributes his expertise as an epilepsy attending at NYC Health Hospitals, specifically at Jacobi Medical Center and North Central Bronx, where he supports the clinical neurophysiology lab.

His extensive background includes completing his neurology residency at the Walter Reed National Military Medical Center, where he later advanced to the rank of Major during his eight years of active duty in the U.S. Army Medical Corps. Throughout his military service, he received numerous decorations and awards for his dedication and contributions to military medicine.

Dr. Correa's military career includes key leadership roles, such as serving as Deputy Chief and later Chief of the Neuroscience & Rehabilitation Center at the Dwight Eisenhower Army Medical Center. There, he was instrumental in clinical education for medical students and residents and served on the Institutional Review Board, fostering a culture of neuroscience research.

His academic interests are centered on traumatic brain injury and the mechanisms of epileptogenesis in post-traumatic epilepsy. In 2019, he completed a Master of Science in Clinical Research Methods at the Albert Einstein College of Medicine, under the mentorship of renowned experts Drs. Solomon L. Moshé and Nathalie Jetté. His current research aims to develop innovative solutions to overcome barriers in recruitment and implementation of neurological and epilepsy research.

Dr. Correa is also passionate about community outreach and has participated in missions to underserved regions, including the Ecuadorian Amazon, where he and his team provided neurological care to 115 patients. He plans to continue bridging the healthcare gap in underserved communities both locally and internationally.

Recommended Articles

• Informing Your Family and Friends about Parkinson's Disease

  If you have Parkinson's, the time for you to explain Parkinson's to your friends and family will certainly come along one day. When this comes, this can definitely put somebody in a pressured state which can be really distressing and agonizing. It is true that anxiousness and discomfort are...

• What Is Erectile Dysfunction: Get the Facts

  Erectile dysfunction (ED) is a condition in which a man is unable to get or maintain an erection long enough during sexual activity to satisfy his sexual needs. The condition was referred as impotence before medical research highlighted the underlying causes. Most men encounter erection problems at...

• Hypolipidemia: Causes and Symptoms

  The liver primarily produces cholesterol. Each day, it makes 1,000 mg of cholesterol. The cells lining the small intestine can also produce cholesterol. If the level of cholesterol in the body is low, it may mean that the body is producing low amounts of cholesterol and is going to shut down. In...

• Aricept for Alzheimer's Disease: Side Effects and Usage

  Generic Name: DonepezilBrand Names: Aricept, Aricept ODTWhat is Aricept?Aricept (donepezil) is a medication used for the treatment of mild to moderate dementia due to Alzheimer's disease. This medication improves nerve function in the brain and works by preventing the breakdown of acetylcholine,...

• As Multiple Sclerosis Urgency Increases, Prices Are Projected to Rise

  Access to affordable health care has been a fundamental question for all developed nations, and remains particularly relevant to the United States today. It is crucial that patients with chronic or life-threatening illnesses have continuous access to quality health care, and that the cost of that...

• Is Multiple Sclerosis Hereditary?

  Research organizations were able to identify and pinpoint two genes that affect the development of multiple sclerosis. Seven genome screens of MS in November 2010 revealed that other complex genetic factors have associations with MS. For this reason, more research is called for to reveal the...